期刊文献+

小剂量乌司他丁对门脉高压脾切除术后患者凝血功能的影响

Effect of low-dose Ulinastatin on blood coagulation function of portal hypertension in patients with splenectomy
下载PDF
导出
摘要 目的观察小剂量乌司他丁对门脉高压脾切除患者术后凝血功能的影响。方法回顾分析115例门脉高压行脾切除患者的临床资料,分对照组(n=68)和乌司他丁组(n=47)。乌司他丁组于术后当日在对照组治疗的基础上给予乌司他丁100000U/d,连用5d。分别在术前、术后1d、3d、5d空腹采血测定凝血酶原时间(PT)、凝血酶原活动度(PTA)、活化部分凝血酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)。结果乌司他丁组于术后3d、5d,胛显著短于术前(均P〈0.01),PTA显著高于术前(均P〈0.01)。与对照组比较,手术后1d、3d、5d,APTT,TT延长,但差异无统计学意义(均P〉0.05)。2组术后门静脉血栓发生率比较差异无显著性(P〉0.05)。结论脾切除术后静脉滴注低剂量乌司他丁100000U/d,可适当延长APTT和TT,改善术后患者的凝血状态,但不能减少术后门静脉血栓形成。 Objective To investigate the effects of low-dose ulinastatin (UTI) on blood coagulation function in patients with portal hypertension after splenectomy. Methods 115 patients with portal hypertension, 77 males and 38 females, aged 46.5 (12-65), undergoing splenectomy were randomly divided into 2 sex, age, liver function, Child-Pugh score, and history of upper digestive system hemorrhage-matched groups: UTI group (n=47) intravenously administered with UTI 100,000 units per day for 5 days in addition to conventional therapy from the operation day to the fourth day after the operation, and control group (n=68) given the conventional therapy. Peripheral blood samples were collected before operation, and 1, 3, and 5 days after operation. Prothrombin time (PT), prothrombin time activity (PTA), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FIB), and D-dimer (D-D) were measured. Results Three and 5 days after operation the PT levels were significantly shorter than that before operation (both P〈0.01), and the PTA levels were significantly longer (both P〈0.01) in the UTI group. The APTT and TT levels 1, 3, and 5 days after operation of the UTI group were longer than those of the control group, however, not significantly (all P〉0.05). The FIB level 5 days after operation of the UTI group was significantly lower than that before operation (P〈0.05), however, there were not significant differences in the FIB levels at different time points in the control group (all P〉0.05). There were not significant differences in the D-D levels at different time points between these 2 groups (all P〉0.05), and there was no significant difference in the perioperative portal vein thrombosis rate between the 2 groups (P〉0.05). Conclusion Low-dose UTI prolongs the APTT and TT, thus modifying blood coagulation status, but cannot prevent pylethrombosis post-operatively.
出处 《中国急救复苏与灾害医学杂志》 2009年第3期161-163,共3页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 脾切除 门静脉高压 乌司他丁 凝血功能 Splenectomy Portal hypertension Ulinastatin Blood coagulation function
  • 相关文献

参考文献7

二级参考文献31

  • 1[1]Fukutake K. In vitro observations on antithrombotic action of urinastatin[J].Nippon Yakurigaku Zasshi, 1987,90(3):163-169.
  • 2[2]Mimura K, Shinozawa K, Kobayashi T, et al.Inhibitory effect of ulinastatin on the alpha-thrombin activation of factors V and VIII[J]. Rinsho Byori, 1992 ,40(3): 317-320.
  • 3[3]Lin SD,Endo R,Sato A,et al. Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis.J Gastroenterol[J]. Hepatology,2002,17(2):140-147.
  • 4[4]Law NL, Ng KF, Irwin MG, et al.Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol[J].Br J Anaesth,2001,86(1):94-98.
  • 5[5]Aoki H, Mizobe T, Nozuchi S,et al. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation[J].Anesthesiology, 1998 ,88(2): 362-370.
  • 6[6]Nii A, Morishita H, Yamakawa T, et al. Design of variants of the second domain of urinary trypsin inhibitor (R-020) with increased factor Xa inhibitory activity[J].J Biochem, 1994 ,115(6):1107-1112.
  • 7[7]Morishita H, Yamakawa T, Matsusue T, et al. Novel factor Xa and plasma kallikrein inhibitory-activities of the second Kunitz-type inhibitory domain of urinary trypsin inhibitor[J].Thromb Res, 1994,73(3-4):193-204.
  • 8[8]Sumi H, Hamada H, Maehara S, et al. Trinitrophenyl-derivative of urinary trypsin inhibitor: a strong antifibrinolytic agent[J].Acta Haematol, 1987,78(4): 225-228.
  • 9[9]Zaitsu M,Hamasaki Y,Tashiro K,et al.Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease[J].J Infect Dis,2000,181(3):1101-1109.
  • 10Abe H, Kumagai K, Matsuda T, et al. Effect of ulinastation on the free radical during cardiopulmonary bypass[J]. Masui, 1995,44(7) :1005-1009.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部